Grifols, S.A.
Pharmaceuticals
Company Summary
Grifols, S.A. is a company that buys, makes, prepares, and sells therapeutic products, particularly hemoderivatives. Bioscience, Hospital, Diagnostic, Bio Supplies, and Others are the company's segments. The firm was established in 1940 and is based in Barcelona, Spain.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
18.1
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
LSEG
Overall ESG Rating :
76
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Grifols is average among 43 companies in the biotechnology industry.
Temperature Rise :
1.7℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
